Firm news

Withers tech works with Morningside Ventures on COVID vaccine enterprise

17 June 2020 | Applicable law: England and Wales

Tech and life sciences focused Withers tech has represented its venture capital client Morningside Ventures on the creation of VaXEquity, alongside Imperial College London.

VaXEquity has been launched to accelerate production of a vaccine to combat COVID-19. In a separate initiative alongside this (on which Withers tech are not advising), Imperial College has partnered with Morningside to distribute the vaccine at a minimum cost plus price through a new social enterprise called VacEquity Global Health, which is supported by both public and private funds.

The Withers tech team was led by partners Susanna Stanfield and Richard Penfold, working with Velyana Borasova, Nadia Gracias, Isaac Black, Libby Payne, Christine Blackman and Sophia Mitropoulos. Withers tech has advised a number of clients on cutting edge initiatives in the fight against COVID-19, including Mologic, which is producing an antibody test.

This document (and any information accessed through links in this document) is provided for information purposes only and does not constitute legal advice. Professional legal advice should be obtained before taking or refraining from any action as a result of the contents of this document.

Share

Related experience

As a full-service law firm, we are able to provide advice and information about a wide range of other issues. Here are some related areas.

Join the club

We have lots more news and information that you'll find informative and useful. Let us know what you're interested in and we'll keep you up to date on the issues that matter to you.